AIV Logo AIV Assistant

Loading...

 Logo Revvity Inc. Common Stock - RVTY Open Revvity Inc. Common Stock in new tab

90.78 USD
P/E
74.12
EPS
1.60
Yield
0.24%
P/B
1.86
ROE
2.51
Beta
1.05
Target Price
139.73 USD

90.7800 USD

90.780 USD

Daily: -25.00%
Key Metrics

Earnings date: Jan. 30, 2026

P/E: 74.12

EPS: 1.60

Book Value: 63.80

Price to Book: 1.86

Debt/Equity: 50.79

% Insiders: 0.275%

Growth

Revenue Growth: -0.03%

Earnings Growth: 0.58%

Estimates

Forward P/E: 22.98

Forward EPS: 5.16

Target Mean Price: 139.73

Dividend

Dividend Yield: 0.24%

Annual dividends: 0.28 USD

Ex-Div. Date: Jan. 16, 2026

Payout: 17.50%

5y avg Yield: 0.23%

DCF Valuation

Tweak assumptions to recompute fair value for Revvity Inc. Common Stock (RVTY)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

 Logo About Revvity Inc. Common Stock - (RVTY)

Country: United States

Sector: Health Care

Website: nan

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Exchange Ticker
NYQ (United States) PKI
SAO (Brazil) P1KI34.SA
MEX (Mexico) PKI.MX
FRA (Germany) PKN.F
LSE (United Kingdom) 0KHE.L
ASE (United States) RVTY
Dividend Yield

0.24% (5y avg: 0.23%)

Annual Dividends

0.28 USD

Next ex. div date

Jan. 16, 2026

Payout Ratio

17.50%

Historical Dividends
Year Total Dividends
2026 0.21 USD
2025 0.28 USD
2024 0.28 USD
2023 0.28 USD
2022 0.28 USD
2021 0.28 USD
2020 0.28 USD
2019 0.28 USD
2018 0.28 USD
2017 0.28 USD
2016 0.28 USD
2015 0.28 USD
2014 0.28 USD
2013 0.28 USD
2012 0.28 USD
2011 0.28 USD
2010 0.28 USD
2009 0.28 USD
2008 0.28 USD
2007 0.28 USD
2006 0.28 USD
2005 0.28 USD
2004 0.28 USD
2003 0.28 USD
2002 0.28 USD
2001 0.42 USD
2000 0.56 USD
1999 0.56 USD
1998 0.56 USD
1997 0.56 USD
1996 0.56 USD
1995 0.70 USD
1994 0.56 USD
1993 0.52 USD
1992 0.56 USD
1991 0.84 USD
1990 0.76 USD
1989 0.68 USD
1988 0.60 USD
1987 0.56 USD
1986 0.52 USD
1985 0.48 USD
1984 0.40 USD
1983 0.27 USD

Yearly aggregated dividends

Dividends

Revvity Inc. Common Stock
Feb 06, 2026 Upcoming
Dividend
0.07 USD
Revvity Inc. Common Stock
Nov 07, 2025 Paid
Dividend
0.07 USD
Revvity Inc. Common Stock
Aug 08, 2025 Paid
Dividend
0.07 USD
Revvity Inc. Common Stock
May 09, 2025 Paid
Dividend
0.07 USD
Revvity Inc. Common Stock
Feb 07, 2025 Paid
Dividend
0.07 USD

Historical Split Corporate Actions

Split Date Split Ratio to 1
June 4, 2001 2.000000
Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion